Clorox (NYSE:CLX) Price Target Lowered to $114.00 at JPMorgan Chase & Co.

Clorox (NYSE:CLX) had its price target cut by JPMorgan Chase & Co. from $120.00 to $114.00 in a research report sent to investors on Friday morning,Benzinga reports. They currently have a neutral rating on the stock.

A number of other research analysts also recently issued reports on the stock. Barclays cut their target price on shares of Clorox from $112.00 to $108.00 and set an “underweight” rating on the stock in a research report on Tuesday, November 4th. Wells Fargo & Company cut their price objective on shares of Clorox from $117.00 to $108.00 and set an “equal weight” rating on the stock in a report on Monday, January 5th. Citigroup lowered their target price on shares of Clorox from $120.00 to $109.00 and set a “neutral” rating for the company in a report on Wednesday, December 17th. Jefferies Financial Group reaffirmed a “buy” rating and set a $152.00 price objective on shares of Clorox in a research note on Tuesday, November 4th. Finally, UBS Group dropped their price objective on Clorox from $119.00 to $115.00 and set a “neutral” rating for the company in a report on Wednesday. One analyst has rated the stock with a Buy rating, fourteen have assigned a Hold rating and four have issued a Sell rating to the company. Based on data from MarketBeat, the company presently has an average rating of “Reduce” and a consensus price target of $122.31.

Clorox Stock Performance

CLX stock opened at $109.95 on Friday. The company has a 50 day moving average price of $103.13 and a 200 day moving average price of $115.32. Clorox has a fifty-two week low of $96.66 and a fifty-two week high of $164.22. The company has a debt-to-equity ratio of 18.01, a current ratio of 0.76 and a quick ratio of 0.50. The stock has a market capitalization of $13.41 billion, a PE ratio of 17.26, a price-to-earnings-growth ratio of 0.55 and a beta of 0.58.

Clorox (NYSE:CLX) last released its earnings results on Monday, November 3rd. The company reported $0.85 EPS for the quarter, beating the consensus estimate of $0.78 by $0.07. Clorox had a return on equity of 358.39% and a net margin of 11.68%.The company had revenue of $1.43 billion during the quarter, compared to analysts’ expectations of $1.41 billion. During the same period last year, the firm earned $1.86 EPS. The business’s revenue for the quarter was down 18.9% on a year-over-year basis. Clorox has set its FY 2026 guidance at 5.950-6.300 EPS. Analysts forecast that Clorox will post 7.15 EPS for the current year.

Clorox Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, February 13th. Shareholders of record on Wednesday, January 28th will be issued a dividend of $1.24 per share. The ex-dividend date is Wednesday, January 28th. This represents a $4.96 annualized dividend and a yield of 4.5%. Clorox’s payout ratio is currently 77.86%.

Insider Transactions at Clorox

In other Clorox news, Director Pierre R. Breber purchased 4,000 shares of the stock in a transaction on Friday, November 21st. The stock was bought at an average cost of $104.13 per share, for a total transaction of $416,520.00. Following the completion of the acquisition, the director directly owned 13,000 shares of the company’s stock, valued at $1,353,690. The trade was a 44.44% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Insiders own 0.63% of the company’s stock.

Institutional Trading of Clorox

A number of large investors have recently bought and sold shares of the business. Total Investment Management Inc. bought a new position in Clorox in the second quarter valued at approximately $25,000. Center for Financial Planning Inc. bought a new stake in Clorox in the 3rd quarter valued at $25,000. Vermillion & White Wealth Management Group LLC acquired a new position in Clorox in the 3rd quarter worth $25,000. American National Bank & Trust increased its holdings in Clorox by 69.5% during the 2nd quarter. American National Bank & Trust now owns 217 shares of the company’s stock worth $26,000 after purchasing an additional 89 shares in the last quarter. Finally, NewSquare Capital LLC raised its stake in shares of Clorox by 567.6% in the 2nd quarter. NewSquare Capital LLC now owns 227 shares of the company’s stock valued at $27,000 after purchasing an additional 193 shares during the period. 78.53% of the stock is owned by institutional investors.

About Clorox

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.